Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Dexmedetomidine in Supraclavicular Brachial Plexus Block
NCT04508894Completed
- Sponsor
- Minia University
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine and dexmedetomidine in pain (3 arms), sponsored by Minia University. Primary endpoint: Duration of sensory block at 24 hours. Started Apr 2019; status: completed.
02
Drugs
ketaminedexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04508894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04508894.